Establishing a routine that includes a consistent time for bowel movements can also help train your body to go more regularly, reducing the likelihood of constipation and straining
Constipation in older adults can also lead to complications such as fecal impaction or bowel obstruction
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally designed for type 2 diabetes management have emerged as one of the most powerful pharmacological tools for sustainable weight reduction
Actin Sequestration and Cytoskeletal Remodeling TB-500 functions as the primary actin-sequestering molecule in the blend, binding globular actin (G-actin) and regulating actin polymerization[2]
According to court filings, Novo Nordisk notified Hims of the patent and its alleged infringement and sent a letter on February 8, 2026, demanding that the company stop its unauthorized use of the technology
Its not unusual for patients to stop taking GLP-1 drugs in the real world beyond these clinical trials, notes Marilyn Tan, MD, a professor at Stanford University School of Medicine and chief of the endocrine clinic at Stanford Health Care in California